USANA Health Sciences - USNA Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $77.33
  • Forecasted Upside: 36.17 %
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$56.79
▼ -0.27 (-0.47%)

This chart shows the closing price for USNA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New USANA Health Sciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for USNA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for USNA

Analyst Price Target is $77.33
▲ +36.17% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for USANA Health Sciences in the last 3 months. The average price target is $77.33, with a high forecast of $122.00 and a low forecast of $53.00. The average price target represents a 36.17% upside from the last price of $56.79.

This chart shows the closing price for USNA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in USANA Health Sciences. This rating has held steady since June 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/14/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/13/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/11/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/9/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/9/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
7/8/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
9/6/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
10/6/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/27/2022DA DavidsonLower TargetOutperform$57.00Low
7/12/2022DA DavidsonLower TargetNeutral$76.00 ➝ $58.00N/A
7/7/2022Jefferies Financial GroupDowngradeHold ➝ Underperform$78.00 ➝ $53.00N/A
4/27/2022DA DavidsonLower Target$86.00 ➝ $76.00High
4/13/2022DA DavidsonInitiated CoverageNeutral$86.00Low
10/8/2021Tigress FinancialReiterated RatingBuy$122.00Low
2/10/2021Roth CapitalBoost TargetBuy$107.00 ➝ $126.00Low
12/17/2020Roth CapitalInitiated CoverageBuy$107.00Low
5/12/2020Tigress FinancialReiterated RatingBuyLow
8/22/2019Jefferies Financial GroupInitiated CoverageHold$65.00Medium
7/24/2019Pivotal ResearchReiterated RatingBuyLow
7/3/2019Pivotal ResearchReiterated RatingBuy$75.00High
7/3/2019SidotiDowngradeBuy ➝ Neutral$70.00High
5/1/2019Pivotal ResearchReiterated RatingBuy$105.00High
4/16/2019Tigress FinancialInitiated CoverageBuy ➝ BuyLow
10/25/2018SidotiUpgradeNeutral ➝ BuyLow
10/24/2018Pivotal ResearchUpgradeHold ➝ Buy$135.00High
7/25/2018Pivotal ResearchReiterated RatingHold$135.00Medium
4/23/2018Pivotal ResearchDowngradeBuy ➝ Hold$95.00High
2/7/2018Pivotal ResearchBoost TargetBuy$80.00 ➝ $95.00Medium
1/24/2018SidotiDowngradeBuy ➝ NeutralMedium
10/25/2017Pivotal ResearchBoost TargetBuy$70.00 ➝ $80.00N/A
(Data available from 10/6/2017 forward)

News Sentiment Rating

0.67 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/10/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/9/2022
  • 4 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/9/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/8/2022
  • 5 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
7/8/2022
  • 3 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/7/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/6/2022
  • 3 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
10/6/2022

Current Sentiment

  • 3 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
USANA Health Sciences logo
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $56.79
Low: $56.33
High: $57.54

50 Day Range

MA: $64.46
Low: $56.05
High: $72.78

52 Week Range

Now: $56.79
Low: $55.40
High: $103.95

Volume

1,357 shs

Average Volume

66,859 shs

Market Capitalization

$1.09 billion

P/E Ratio

12.51

Dividend Yield

N/A

Beta

0.78

Frequently Asked Questions

What sell-side analysts currently cover shares of USANA Health Sciences?

The following Wall Street research analysts have issued research reports on USANA Health Sciences in the last twelve months: DA Davidson, Jefferies Financial Group Inc., StockNews.com, TheStreet, and Tigress Financial.
View the latest analyst ratings for USNA.

What is the current price target for USANA Health Sciences?

3 Wall Street analysts have set twelve-month price targets for USANA Health Sciences in the last year. Their average twelve-month price target is $77.33, suggesting a possible upside of 36.2%. Tigress Financial has the highest price target set, predicting USNA will reach $122.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $53.00 for USANA Health Sciences in the next year.
View the latest price targets for USNA.

What is the current consensus analyst rating for USANA Health Sciences?

USANA Health Sciences currently has 1 sell rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in USNA, but not buy more shares or sell existing shares.
View the latest ratings for USNA.

What other companies compete with USANA Health Sciences?

How do I contact USANA Health Sciences' investor relations team?

USANA Health Sciences' physical mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company's listed phone number is (801) 954-7100 and its investor relations email address is [email protected] The official website for USANA Health Sciences is www.usana.com. Learn More about contacing USANA Health Sciences investor relations.